Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 8, 2014, Pages 1058-1067

  Niebuhr, M ^a   Baumert, K ^a   Heratizadeh, A ^a   Satzger, I ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

atopic dermatitis; lipoteichoic acid; NLRP3; psoriasis; toxin

Indexed keywords

CRYOPYRIN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; STAPHYLOCOCCUS ALPHA TOXIN; BACTERIAL TOXIN; CARRIER PROTEIN; CYTOKINE; HEMOLYSIN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN; STAPHYLOCOCCAL ALPHA-TOXIN;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

BACTERIAL TOXINS; CARRIER PROTEINS; CASPASE 1; CYTOKINES; DERMATITIS, ATOPIC; DOWN-REGULATION; GENE EXPRESSION; HEMOLYSIN PROTEINS; HUMANS; INFLAMMASOMES; KERATINOCYTES; MONOCYTES; PSORIASIS; SKIN; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 84904039705     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12428     Document Type: Article

References (30)

1. Boguniewicz M, Leung DYM,. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010; 125: 4-13.
2. Marples RR, Heaton CL, Kligman AM,. Staphylococcus aureus in psoriasis. Arch Dermatol 2005; 107: 568-570.
3. Tomi NS, Kränke B, Aberer E,. Staphylococcal toxins in patients in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005; 53: 67-72.
4. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA,. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 2009; 129: 14-30.
5. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006; 24: 317-327.
6. Munoz-Planillo R, Franchi L, Miller LS, Nunez G,. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the NLRP3 inflammasome. J Immunol 2009; 183: 3942-3948.
7. Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E,. Inflammasomes and host defenses against bacterial infection. Curr Opin Mincrobiol 2013; 16: 23-31.
8. Jin C, Flavell RA,. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 2010; 30: 628-631.
9. Meng G, Zhang F, Fuss I, Kitani A, Strober W,. A NLRP3 mutation causing inflammasome hyperactivation potentiates Th17 dominated immune responses. Immunity 2009; 30: 860-874.
10. Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T,. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007; 120: 69-75.
11. Zweiman B, Kaplan AP, Tong L, Moskovitz AR,. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997; 100: 104-109.
12. Niebuhr M, Lutat C, Sigel S, Werfel T,. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 2009; 64: 1580-1587.
13. Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, et al. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 2011; 127: 806-814.
14. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, Hirota T,. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 2009; 124: 779-785.
15. Watanabe H, Gaide O, Patrilli V, Martinon F, Contassot E, Roques S, et al. Activation of the IL-1β-Processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 2007; 127: 1956-1963.
16. Weber FC, Esser PR, Müller T, Ganesan J, Pellegatti P, Simon MM, et al. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med 2010; 207: 2609-2619.
17. Niebuhr M, Langnickel J, Begemann G, Baumert K, Draing C, Werfel T,. Dysregulation of TLR-2 induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism. Allergy 2008; 63: 728-734.
18. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.): 44-47.
19. Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T,. Human keratinocytes respond to Interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 2005; 124: 1225-1233.
20. Wang D, Drenker M, Eiz-Vesper B, Werfel T, Wittmann M,. Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum 2008; 58: 3205-3215.
21. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-TeKippe E, et al. Staphylococcus aureus α-Hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009; 4: e7446.
22. Chen S, Sun B,. Negative regulation of NLRP3 inflammasome signaling. Protein Cell 2013; 4: 251-258.
23. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, et al. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009; 460: 269-273.
24. Kopfnagel V, Harder J, Werfel T,. Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr Opin Allergy Clin Immunol 2013; 13: 531-536.
25. Bhakdi S, Muhly M, Korom S, Hugo F,. Release of Interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immunol 1989; 57: 3512-3519.
26. Miller LS, Pietras EM, Uricchio LH, Hirano K, Rao S, Lin H, et al. Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol 2007; 179: 6933-6942.
27. Xiang Y, Wang X, Yan C, Gao Q, Li SA, Liu J, et al. Adenosine-5′- Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome. PLoS One 2013; 8: e63759.
28. Johnson KE, Chikoti L, Chandran B,. Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol 2013; 87: 5005-5018.
29. Breuer K, Wittmann M, Kempe K, Kapp A, Mai U, Dittrich-Breiholz O, et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005; 35: 1088-1095.
30. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U, et al. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009; 161: 300-305.